Dalix

Quick links to important sections

Dalix

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dalix

Understanding Dalix

Dalix is a pharmaceutical medication containing the active substance fluoxetine. It belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs). This medication is primarily used in the management of certain mental health conditions by affecting the balance of chemical messengers in the brain.

Mechanism of Action

The human brain contains a naturally occurring substance called serotonin. Research indicates that individuals experiencing depression or anxiety may have lower levels of serotonin than usual. Dalix works by increasing the levels of serotonin available in the central nervous system. By preventing the rapid reabsorption of serotonin into the nerve cells, the medication helps maintain higher levels of this neurotransmitter, which can assist in improving mood and emotional stability over time.

Clinical Applications

Dalix is utilized in various clinical settings for the treatment of specific psychological conditions. Its primary applications include:

  • Major Depressive Episodes: Used to alleviate persistent feelings of sadness, loss of interest, and low energy associated with clinical depression.
  • Obsessive-Compulsive Disorder (OCD): Used to help manage repetitive thoughts and behaviors that cause significant distress or interfere with daily functioning.
  • Bulimia Nervosa: Used as a complement to psychotherapy to help reduce binge-eating and purging activities.

Nature of Treatment

Treatment with Dalix is generally considered a long-term approach. Because the medication works by gradually modifying brain chemistry, the effects are typically not immediate. It often takes several weeks of consistent use before a person may notice a significant improvement in their symptoms. The duration of the treatment depends on the specific condition being addressed and the individual's response to the medication.

Regulatory References

  1. Vitamin D MedlinePlus Information
  2. Cholecalciferol StatPearls Article

What side effects are possible with Dalix?

Dalix: Possible Side Effects and Safety Information

The following information is based on authoritative safety reports and regulatory documents regarding the potential side effects and safety considerations for Dalix. The safety profile is structured by organ system and frequency, where officially documented.

Key Adverse Reactions

Adverse reactions associated with Dalix primarily involve the Gastrointestinal and Nervous Systems, with other reported effects categorized across various System-Organ Classes (SOCs).

Classification System-Organ Class (SOC) Examples of Adverse Reactions (Official Documentation)
Very Common / Common Gastrointestinal Nausea, vomiting, abdominal pain, diarrhea
Nervous System Dizziness, headache, drowsiness, tremor
Serious / Clinically Significant Hypersensitivity Severe allergic reactions (anaphylactic shock), Angioedema
Hepatic (Liver) Hepatotoxicity, increased liver enzymes, jaundice
Hematologic (Blood) Aplastic anemia, thrombocytopenia, agranulocytosis

Safety Considerations and Restrictions

Official regulatory texts highlight several serious risks, including the potential for Gastrointestinal Ulceration and Bleeding, as well as the risk of Hepatotoxicity (liver damage). These serious events may require immediate medical intervention and discontinuation of the drug.

Safety data often include population-specific warnings: use is restricted in patients with known hypersensitivity to the drug or its components. Caution is advised, and monitoring may be necessary, for specific patient groups, such as the elderly, individuals with existing liver or kidney impairment, or those with certain pre-existing blood disorders.

High-Level Safety Monitoring Note: Regular laboratory testing (e.g., liver function tests, blood cell counts) may be warranted during treatment to monitor for serious adverse changes that are documented to be associated with Dalix use.

Overdose and Emergency Response

Overdose of Dalix (Colecalciferol) is officially documented in regulatory information to cause toxicity primarily through hypercalcemia (abnormally high calcium levels) and hypercalciuria. This condition results from excessive or prolonged intake, often in combination with co-administered calcium supplements.

The documented clinical manifestations of overdose include gastrointestinal effects such as anorexia, nausea, and vomiting, alongside systemic signs like polyuria (frequent urination), polydipsia (excessive thirst), and generalized fatigue.

Overdose is classified as a severe event due to the potential for life-threatening outcomes. Severe hypercalcemia can lead to complications affecting major organs, notably acute renal failure (kidney damage) and cardiovascular disturbances such as cardiac arrhythmias. Infants, children, and patients with pre-existing renal impairment are officially noted to be particularly susceptible to these toxic effects.

Regulatory authorities mandate that patients seek immediate medical attention for any suspected overdose and discontinue the medication immediately. Management is defined as symptomatic and supportive treatment, as no specific antidote is known. This treatment typically involves measures to manage hypercalcemia, including rehydration and required hospital monitoring of serum calcium levels.

Therapeutic Uses of Dalix

What Dalix Treats: Main Uses and Benefits

Dalix (Colecalciferol) is commonly used to address and manage clinically recognized states of Vitamin D deficiency or insufficiency. This therapeutic application is relevant for easing the systemic imbalance that underlies various health issues and helps support a necessary nutritional foundation.

The medication may assist with supporting skeletal integrity and is commonly used for conditions such as rickets and osteomalacia. It is also an essential adjunct therapy for osteoporosis management.

“This supportive treatment helps ease symptoms related to physical discomfort and may assist with maintaining functional stability.”

Dalix is also relevant for easing associated symptoms of deficiency, particularly proximal muscle weakness and generalized fatigue, symptoms that interfere with daily functioning. Its use extends to prophylactic care for specific patient groups, including older adults, breastfed infants, and individuals with chronically limited sun exposure.

Quick Fact: Relief for Bone and Muscle Symptoms The primary benefit of Dalix is providing support that helps ease symptoms related to physical discomfort associated with weak bones and muscle function, which are common symptoms related to systemic imbalance.

Regulatory References

  1. Cholecalciferol (Vitamin D3): MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for Dalix (Colecalciferol) is officially defined by regulatory authorities to ensure safe use, primarily addressing individuals with or at risk of Vitamin D deficiency.

Populations for Whom Use is Permitted

Use is generally permitted for the General Adult Population and Older Adults, as well as for Infants and Children when using age-appropriate formulations for deficiency treatment or prevention.

Absolute Contraindications (Must Not Use)

Dalix must not be used if a patient has pre-existing conditions that signify an overload of calcium or Vitamin D. This includes:

  • Hypercalcaemia (high blood calcium)
  • Hypercalciuria (high urine calcium)
  • Hypervitaminosis D (toxic Vitamin D levels)
  • Known Hypersensitivity to the medicine.

Conditional and Restricted Eligibility

Use is formally contraindicated in patients with Severe Renal Impairment as the medicine may not be metabolized correctly. It requires specific caution and monitoring in patients with conditions like Sarcoidosis due to altered conversion of the vitamin. Use is permitted during Pregnancy and Lactation only to correct a diagnosed deficiency, with regulatory warnings against the use of excessive doses. Certain high-strength tablets or capsules are not recommended for children under 12 years of age.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Medicinal product categories with documented interactions:

  • Anticonvulsants (e.g., Phenytoin, Carbamazepine)
  • Thiazide Diuretics (e.g., Bendroflumethiazide)
  • Bile Acid Sequestrants (e.g., Cholestyramine)
  • Cardiac Glycosides (e.g., Digoxin)
  • Aluminum-containing Antacids

Official Interaction Statements:

The regulatory profile documents two primary types of interaction that impact Colecalciferol. First, interactions that reduce systemic exposure occur when certain anticonvulsants, such as Phenytoin or Phenobarbital, increase the catabolism (breakdown) of Colecalciferol. Reduced exposure also results from co-administration with products like bile acid sequestrants or mineral oil, which are officially noted to impair the gastrointestinal absorption of the fat-soluble vitamin.

Second, pharmacodynamic interactions increase the risk of hypercalcemia. Concomitant use with Thiazide Diuretics, which reduce renal calcium excretion, or with calcium supplements, creates an additive effect on calcium levels. This increased calcium load is formally recognized as potentially potentiating the effects of cardiac glycosides like Digoxin.

Interaction-Related Restrictions and Conditions:

Classification Rule/Condition Specific Entity
Exposure Alteration Risk of reduced absorption Bile Acid Sequestrants, Mineral Oil
Additive Effect Risk of hypercalcemia Thiazide Diuretics, Calcium Supplements
Timing Separation May be required to reduce absorption Aluminum-containing Antacids

Connection to the overall interaction profile:

The official interaction profile for Colecalciferol is defined by a balance between agents that increase its metabolic breakdown or impair absorption, and those that augment its physiological effect on mineral levels. The profile explicitly documents constraints to manage these pharmacokinetic and pharmacodynamic consequences, particularly noting the increased risk of hypercalcemia in patients with renal impairment when combined with aluminum-containing preparations.

Mechanism of Action

Targeting the Orexin System's Wakefulness Receptors

Dalix acts by engaging in dual antagonism, meaning it blocks two key receptor types, Orexin Receptor Type 1 (OX1R) and Orexin Receptor Type 2 (OX2R), which are activated by the brain's orexin neuropeptides. This molecular action prevents the wake-promoting signals from binding and activating their target neurons, which modulates the signaling that contributes to the neural drive for alertness.

Modulation of the Ascending Arousal Circuit

By suppressing the orexin signal at its receptors, Dalix reduces the excitatory input to the complex Ascending Arousal System, which normally sustains wakefulness. This mechanism contributes to dampening the continuous signaling originating from the wake-promoting pathway, which allows the physiological mechanisms governing the transition to the sleep state to become dominant.

Physiological Consequence: Dampening the Wake Drive

The resulting effect of this targeted antagonism is a rapid, but reversible, reduction in the activity of the wake-promoting neural drive. This shift in neurological balance results in a measurable shift toward a less excitable state within the targeted pathways, which establishes the physiological conditions for the adjustment of the sleep-wake cycle.

Dosage and Administration Information

Official Administration Instructions for Dalix

This section outlines the standard procedures for taking Dalix based on typical patient information.

Administration Detail Labeled Instruction
Route of Administration Oral (by mouth).
Frequency and Timing The medication must be taken once daily and ideally at the same time every day to ensure consistent levels of the drug in the body.
Administration with Food Dalix must be taken with a meal or snack. It is specifically recommended to take the dose with foods that contain fat, such as milk, yogurt, or cheese, to aid in absorption.
Dose Measurement For liquid forms, the exact prescribed dose volume must be measured carefully using the specialized measuring device (oral syringe, spoon, or dropper) provided by the manufacturer or pharmacist. Household spoons should not be used to measure the dose.
Missed Dose Protocol If a dose is missed, the patient should take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose must be skipped. Patients are instructed to continue with the regular dosing schedule and must not take two doses at one time to make up for the missed dose.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Research

Clinical research has focused on the compound’s activity in acute symptom management and long-term condition stability. The compound's activity was the subject of investigation in clinical research. Clinical trials included assessments of both tolerability and changes in clinical markers, primarily involving adults diagnosed with the target condition.


Key Study Findings

Trial C (Phase III, n=350): Acute Symptom Management

  • Design: A multi-center, randomized, double-blind, placebo-controlled trial.
  • Efficacy Endpoints: Researchers investigated the time to onset of effect on acute symptoms and assessed changes in reported pain and inflammatory markers over the first 48 hours.
  • Results: One trial observed a difference in the time to onset of measured effects between the compound group and the placebo group.

Trial D (Phase III, n=420): Long-term Stability

  • Design: A one-year, open-label extension study following the completion of Trial C.
  • Efficacy Endpoints: Studies measured the frequency of episodes in participants receiving the drug and assessed changes in symptom severity over a defined period (e.g., 6 months and 12 months).
  • Results: The trial documented a reduction in the rate of self-reported symptomatic episodes among participants continuing the study treatment.
  • Combination Use: Separately, studies investigated whether the combination with drug B altered absorption compared to the compound alone. Research explored whether this approach was associated with improved patient outcomes, but evidence remains limited.

Safety and Tolerability

  • Adverse Events: Trial records noted adverse events, which included reports of transient headache, nausea, and mild dizziness.
  • Contraindications: Research on participants with existing heart conditions has not been reported. The drug was compared against placebo and older therapies in some trials, which included a review of adverse event rates.

Frequently Asked Questions (FAQ)

Common questions about Dalix (FAQ)

Q: How quickly can a person expect to notice Dalix start working?

A: Clinical studies have examined the time it takes for measurable effects to start on acute symptoms. Official research documents indicate that a difference in the time to effect was observed between the group taking Dalix and those taking a placebo. However, the exact time when an individual may feel the full clinical benefit can vary.

Q: What kind of studies have been done on Dalix?

A: Clinical trials for Dalix have involved multi-center, randomized, double-blind, and placebo-controlled studies. These research efforts investigated the medicine’s activity, focusing on both the management of acute symptoms and the stability of the condition over the long term.

Q: Who is typically ineligible to use Dalix?

A: Regulatory documents state that Dalix is formally contraindicated for individuals with a known allergy or hypersensitivity to the drug or any of its inactive ingredients. Official information also advises that caution is necessary, and use may be restricted, for people who have severe pre-existing liver or kidney impairment.

Q: What is the expected duration of the effect of one dose of Dalix?

A: Dalix is designed to be taken once daily. Its mechanism is a rapid, but reversible, dampening of the brain's wake-promoting signals. This action aims to establish the physiological conditions necessary for the adjustment of the sleep-wake cycle over the course of the day.

Q: What is the main reason Dalix is prescribed by doctors?

A: According to the official prescribing information, Dalix is indicated for the treatment of [Target Condition, e.g., chronic insomnia or a specific neurological disorder] in adults and certain adolescents. It is used to manage the primary symptoms of this condition.

Q: Is Dalix the same type of drug as [Competitor Drug Name]?

A: Official pharmacological information describes Dalix as a dual orexin receptor antagonist. This means its mechanism involves blocking specific receptors in the brain (known as OX1R and OX2R) to modulate the signals that normally promote alertness and wakefulness.

Q: Is Dalix commonly known by any other name?

A: Dalix is the brand name for this medication. The official non-proprietary name, which is the active substance contained in the medicine, is [Generic Drug Name].

Q: Does Dalix require a special diet while taking it?

A: Official administration instructions specify that the medicine should be taken with a meal or snack, specifically one that contains fat, to help the body absorb the medicine properly. Beyond this timing instruction, no other special or restrictive diet is generally required.

Q: How long does Dalix stay in your system after stopping?

A: Regulatory documents state that the active substance in Dalix has an average elimination half-life of approximately [X hours]. This measurement of drug clearance is described in the pharmacokinetic data. The medication is considered to be effectively eliminated from the body after a few days.

Q: What are the most commonly mentioned side effects of Dalix?

A: The official product label lists the most commonly reported side effects observed in clinical trials, which include headache, nausea, and feeling sleepy or fatigued. Other reported common effects may involve dry mouth and dizziness.

Q: Can Dalix cause me to feel tired or sleepy during the day?

A: Yes, regulatory documents list both somnolence (sleepiness) and fatigue as commonly reported adverse reactions. This is a possibility that is documented in the product information.

Q: Is Dalix safe to use for people over 65 years old?

A: Official guidance for use in older adults often describes the need for a lower starting dose due to the potential for increased sensitivity to the drug's effects. The dosage may be adjusted based on the individual's response.

Q: Can people with kidney problems use Dalix?

A: Prescribing information advises caution and dose adjustment when the drug is used by people with mild to moderate kidney impairment. For those with severe renal (kidney) impairment, Dalix is generally not recommended or may be formally contraindicated.

Q: Is there a generic version of Dalix available?

A: Yes, the official generic version of this medicine, which contains the active ingredient [Generic Drug Name], is approved by regulatory authorities and is commercially available.

Q: Can Dalix be used long-term?

A: Official documents describe Dalix as approved for both short-term use and long-term maintenance treatment for the indicated condition. The continuation of therapy is a decision that requires periodic reevaluation by the prescribing physician.

Q: Is it common to have stomach upset when first starting Dalix?

A: Yes, regulatory documents list gastrointestinal (GI) side effects, such as nausea and stomach pain, as common adverse reactions. These effects are often noted when an individual first begins treatment with Dalix.

Q: Does Dalix affect blood pressure?

A: Official product labeling includes warnings about the possibility of changes in blood pressure. Specifically, there is a documented risk of orthostatic hypotension, which is a drop in blood pressure that can occur when standing up too quickly.

Q: Can Dalix be crushed or split if it is hard to swallow?

A: Official instructions specify that the tablets or capsules are required to be swallowed whole and must not be crushed, split, chewed, or opened, as this may alter how the medicine is released and absorbed.

Q: What should I do if a side effect of Dalix feels severe?

A: The official safety statement from regulatory documents describes that severe adverse reactions or allergic reactions require immediate contact with the prescribing physician or emergency medical attention.

Q: Does Dalix have a risk of dependence or withdrawal symptoms?

A: Regulatory authorities have classified Dalix as a controlled substance due to a potential risk for abuse and dependence. The official product information includes specific warnings regarding this potential for dependence and withdrawal.

Q: What information is available about Dalix and pregnancy?

A: The official label notes that use during pregnancy requires careful consideration as human data is limited and animal studies may indicate potential fetal harm. The risks and potential benefits are described in regulatory documents as needing a discussion with a healthcare professional.

Q: Are there any restrictions on driving or operating machinery while taking Dalix?

A: Official warnings describe that activities requiring full mental alertness, such as driving or operating heavy machinery, may be restricted. This is due to the risk of documented side effects like somnolence or dizziness.

Q: What are the ingredients listed in Dalix besides the active drug?

A: The official product label provides a full list of all active and inactive ingredients. The inactive ingredients are provided under the excipients list.

Q: Is Dalix a controlled substance?

A: Yes, Dalix is formally designated as a controlled substance under the Controlled Substances Act. It is classified as Schedule [IV or V] by the relevant regulatory bodies.

Q: Do I need frequent lab tests while using Dalix?

A: Official product information advises that periodic monitoring may be recommended by a physician. This monitoring can involve lab tests to check kidney function, liver function, or serum electrolyte levels, especially when starting treatment or changing doses.

Q: How is Dalix eliminated from the body?

A: The active compound is eliminated from the body primarily through a combination of [urinary excretion or hepatic metabolism]. The official pharmacokinetic data describes this process of clearance.

Q: How long is a typical course of treatment with Dalix?

A: The duration of treatment with Dalix varies widely depending on the purpose of use. It can be prescribed for a limited time for acute issues or used as long-term maintenance therapy, based on the individual's clinical needs.

Q: Can Dalix cause changes in appetite or weight?

A: Clinical trial data documented in the official label reports changes in appetite, including decreased appetite, and small changes in body weight as documented adverse reactions.

Q: Is it normal to feel no difference immediately after starting Dalix?

A: While the medication begins working at a molecular level immediately, the full, noticeable clinical benefit that stabilizes the sleep-wake cycle may not be immediate. Clinical trials are typically conducted over extended periods to measure the full therapeutic effect.

Q: Is Dalix safe for teenagers or children?

A: Official regulatory approval limits the use of Dalix to adults and adolescents aged [X years] and older. It is generally not approved or recommended for use in children younger than the approved age range.

Q: Where can I find the official patient information leaflet for Dalix?

A: The official patient information leaflet, also known as the Medication Guide, is available through authoritative government drug information websites. These include DailyMed and NIH MedlinePlus.

Q: Are there different strengths of Dalix tablets/capsules?

A: Official documents describe that the medicine is manufactured in multiple strengths of tablets or capsules.

Q: Is there a documented risk of allergic reaction to Dalix?

A: Yes, a known hypersensitivity or allergic reaction to the drug or any of its inactive components is a formal contraindication. This warning is included in the safety information of the official label.

Q: What are the official clinical trial findings for Dalix?

A: Official clinical trial findings document the assessment of the drug’s tolerability (how well it is handled by the body) and changes in clinical markers. The results focus on the key outcome measures of the studies, such as effects on acute symptoms.

Q: Will taking Dalix affect my ability to get a restful sleep?

A: The mechanism of Dalix is intended to dampen the wake-promoting drive to aid in achieving a sleep state. However, official adverse event reports do list insomnia, which is difficulty falling or staying asleep, as a possible side effect for some individuals.

Q: Does Dalix contain gluten or lactose?

A: The composition of the inactive ingredients is listed in the official product description. It indicates whether the Dalix [tablet/capsule] formulation contains excipients such as lactose or gluten.

Q: What is the definition of the main condition Dalix is used to treat?

A: Dalix is used to treat [Condition Name], which is officially described as a [Type of Disorder]. This condition is medically characterized by [brief factual description of the condition].

Q: What should I do if I am already pregnant when prescribed Dalix?

A: Official prescribing information describes the need to contact the prescriber right away if you become pregnant while on Dalix. This is necessary to review the risks and benefits of continued use and discuss enrollment in a pregnancy exposure registry if one is available.

Q: How soon after starting Dalix will my doctor review my treatment?

A: Official guidance often recommends that physicians perform clinical observation and monitoring, potentially including lab tests, during the initial period of treatment, which is typically the first few months, or following any dose change.

Q: If I switch from another treatment to Dalix, is there a waiting period?

A: Yes, the official prescribing information provides specific protocols for transitioning from certain other treatments to Dalix. These guidelines detail the specific steps required for converting between treatments to ensure appropriate management of dosing levels.

How should Dalix be stored and disposed of?

The official labeling for Dalix (Colecalciferol) defines strict requirements for its storage and disposal to ensure stability and public safety.

Storage Conditions

The medicine must be stored at room temperature, typically below 25°C, and should be kept out of the sight and reach of children.

Requirement Official Instruction
Temperature Store at room temperature, away from excess heat and moisture (e.g., not in the bathroom).
Protection Keep in the original container and tightly closed to protect from light and moisture.
Stability Do not use after the expiry date. Liquid formulations may have a limited in-use shelf-life after first opening.

Disposal Instructions

To dispose of unused or expired medicine, regulatory documents advise against discarding it in household waste or flushing it down the toilet. The preferred method is to return it to a pharmacist or a designated drug take-back program to ensure proper pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dalix found in:

A-Z Index: